Emerging nanotechnologies and microbiome engineering for the treatment of inflammatory bowel disease OA Abed, Y Attlassy, J Xu, K Han, JJ Moon Molecular pharmaceutics 19 (12), 4393-4410, 2022 | 9 | 2022 |
Characterizing Escherichia coli’s transcriptional response to different styrene exposure modes reveals novel toxicity and tolerance insights M Machas, G Kurgan, OA Abed, A Shapiro, X Wang, D Nielsen Journal of Industrial Microbiology and Biotechnology 48 (1-2), kuab019, 2021 | 8 | 2021 |
Vaccines for immune tolerance against autoimmune disease A Kim, F Xie, OA Abed, JJ Moon Advanced drug delivery reviews, 115140, 2023 | 2 | 2023 |
Applying a ‘Metabolic Funnel’ for Phenol Production in Escherichia coli B Thompson, M Machas, O Abed, DR Nielsen Fermentation 7 (4), 216, 2021 | 1 | 2021 |
Strategies for the development of metalloimmunotherapies X Sun, X Zhou, X Shi, OA Abed, X An, YL Lei, JJ Moon Nature Biomedical Engineering, 1-19, 2024 | | 2024 |